initial public offerings (IPOs) trading on American exchanges

Wednesday, January 8, 2020

LMP Automotive (LMPX) began trading on the Nasdaq on Thur 5 Dec 2019

LMP is an e-commerce platform for buying, selling and financing late model pre-owned automobiles. Through the Company’s platform, consumers can research and identify a vehicle, obtain financing and warranty coverage, purchase a vehicle and schedule delivery or pick-up all from their desktop or mobile devices.

  • Share Price $5.00
  • Employees 11 (as of 05/18/2019)
  • Shares Offered 2300000
  • Offer amount $11,500,000
  • Shares Outstanding 8,301,639
  • Lockup Period (days) 180
  • Lockup Expiration 06/02/2020
  • Quiet Period Expiration 01/14/2020
  • Website www.lmpmotors.com


Samer Tawfik - CEO, Founder & Executive Director

Tuesday, January 7, 2020

-=Apellis Pharma (APLS) : head-to-head trial vs. Alexion (ALXN)


  • A strong showing in a Phase 3 head-to-head trial in patients with rare blood disease has sent shares of the small biotech Apellis Pharmaceuticals soaring.


Shares of Apellis Pharmaceuticals (APLS) rocketed Tuesday after the biotech company's experimental drug outperformed Alexion Pharmaceuticals' (ALXN) blockbuster, Soliris, in a head-to-head test.

The biotech company tested its drug, dubbed pegcetacoplan, in patients with a blood disorder called paroxysmal nocturnal hemoglobinuria, or PNH. A rare disorder, PNH destroys red blood cells and blood clots, and impairs bone marrow function.

At week 16 of the study, patients who received pegcetacoplan showed a stronger increase in hemoglobin vs. those who took Soliris, Apellis said in a news release. Hemoglobin is a protein responsible for transporting oxygen in the blood.

"Pegcetacoplan is the first and only investigational therapy to demonstrate superiority compared to (Soliris) on hemoglobin levels," Apellis Chief Medical Officer Federico Grossi said in a written statement. "We are also excited to see 85% of patients treated with pegcetacoplan were transfusion free."

Monday, January 6, 2020

====Care.com (CRCM) to be acquired by IAC (IAC) for $500M

 
Dec 20, 2019
New York-based media and internet holding company IAC is acquiring the online marketplace Care.com Inc. in an all-cash transaction valued at $500 million, the companies announced Friday.

Waltham-based Care.com, which seeks to match caregivers with families, launched in 2007 and became a public company in January 2014. The company also has offices in San Francisco, Berlin and Austin.

Its matching services cover senior care, child care, pet care and housekeeping, among others. The company said its network includes 19.8 families and 14.3 million caregivers.

IAC (Nasdaq: IAC) is acquiring Care.com (NYSE: CRCM) for $15 per share, a 34 percent premium to the company’s closing stock price on Oct. 25. IAC has majority ownership in companies that covers travel, dating and home services such HomeAdvisor, and Angie’s List. Earlier this year, IAC said it plans to spin off its majority stake in the Match Group, which includes the dating services Tinder, Match, OkCupid and Hinge.